A new, pioneering procedure was used to treat a record number of prostate patients in a day. Frimley Health NHS Foundation trust were able to break their record thanks to the use of a robot-assisted ...
In 2020, shortly before he retired from a career working in information technology (IT), David Green's lifestyle included lifting weights, playing golf, doing house and yard work and hanging out with ...
The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...
Hosted on MSN
Treatment developed for advanced prostate cancer that could eliminate severe side effects
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
The ARID II trial investigates the Voro Urologic Scaffold's safety and efficacy in prostate cancer patients undergoing robotic-assisted radical prostatectomy. The scaffold aims to improve urinary ...
Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...
A new treatment for advanced prostate cancer can halt and even shrink tumours, 'remarkable' trials have shown. Early tests of the immunotherapy, which harnesses the body's immune system to fight ...
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...
Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...
Despite previous research pointing to a substantial increase in global prostate cancer mortality in the future, Isaac Y. Kim, ...
A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results